# The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)

> **NCT00385944** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 56 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00385944
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2010-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385944, "The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00385944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*